EZZ Life Science Holdings Limited
EZZ Life Science Holdings Limited
Your view on EZZ.AX
Overview
What the company does, where it operates, and who runs it.
About EZZ Life Science Holdings Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Mark Qin
- Headquarters
- Shop 1, 55-59 Parramatta Road, Lidcombe, NSW, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Mark Qin
- Headquarters
- Shop 1, 55-59 Parramatta Road, Lidcombe, NSW, AU
EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories.
The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores.
Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines.
These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for EZZ Life Science Holdings Limited. Starting points for EZZ Life Science Holdings Limited: EPS -AUD 0.11, beta 0.91 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for EZZ Life Science Holdings Limited. EZZ Life Science Holdings Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for EZZ Life Science Holdings Limited. Trailing twelve-month EPS for EZZ Life Science Holdings Limited stands at -AUD 0.11. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This yearYear to Jun 2027 |
|---|---|
| Average estimate | AUD 0.24 |
| Lowest estimate | AUD 0.24 |
| Highest estimate | AUD 0.24 |
| Number of analysts | 1 |
| A year ago | −AUD 0.111 |
| Growth vs a year ago | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This yearYear to Jun 2027 |
|---|---|
| Average estimate | AUD 105.10M |
| Lowest estimate | AUD 105.10M |
| Highest estimate | AUD 105.10M |
| Number of analysts | 1 |
| A year ago | AUD 46.28M |
| Growth vs a year ago | +127.1% |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for EZZ Life Science Holdings Limited. EZZ Life Science Holdings Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ACW.AXActinogen Medical Limited | Healthcare | Biotechnology | — | ||
| ALA.AXArovella Therapeutics Limited | Healthcare | Biotechnology | — | ||
| ATH.AXAlterity Therapeutics Limited | Healthcare | Biotechnology | — | ||
| BIO.AXBiome Australia Limited | Healthcare | Medical - Pharmaceuticals | — | ||
| ILA.AXIsland Pharmaceuticals Limited | Healthcare | Biotechnology | — | ||
| IMU.AXImugene Limited | Healthcare | Biotechnology | — | ||
| PCK.AXPainChek Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| RCE.AXRecce Pharmaceuticals Ltd | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PEPGPepGen Inc. | Healthcare | NASDAQ | $265.3M | ||
| PFNDPathfinder Cell Therapy, Inc. | Healthcare | OTC | $66,716 | ||
| PGENPrecigen, Inc. | Healthcare | NASDAQ | $1.5B | ||
| PHARPharming Group N.V. | Healthcare | NASDAQ | $882.4M | ||
| PHATPhathom Pharmaceuticals, Inc. | Healthcare | NASDAQ | $430.8M | ||
| PHGUFPharming Group N.V. | Healthcare | OTC | $1.1B | ||
| PHIOPhio Pharmaceuticals Corp. | Healthcare | NASDAQ | $8.6M | ||
| PHMMFPharma Mar, S.A. | Healthcare | OTC | $1.5B | ||
| PHRM.CNPharmaTher Holdings Ltd. | Healthcare | CNQ | $9.1M | ||
| PHRRFPharmaTher Holdings Ltd. | Healthcare | OTC | $5.3M | ||
| PHVSPharvaris N.V. | Healthcare | NASDAQ | $2.2B | ||
| PHYOFIXICO plc | Healthcare | OTC | $6.5M | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of EZZ Life Science Holdings Limited.